Medicine & Life Sciences
Breast Neoplasms
87%
Neoplasms
82%
Patient Care Planning
68%
Oncologists
57%
durvalumab
57%
Terminal Care
46%
Triple Negative Breast Neoplasms
40%
Drug Therapy
39%
Quality of Health Care
38%
Clinical Trials
34%
130-nm albumin-bound paclitaxel
34%
Medicare
34%
Hospitalists
32%
Cyclophosphamide
28%
Therapeutics
28%
Hospices
27%
Hospital Emergency Service
26%
Communication
23%
Costs and Cost Analysis
23%
Inpatients
22%
Practice Guidelines
22%
Non-Small Cell Lung Carcinoma
22%
orteronel
21%
Patient Satisfaction
20%
Doxorubicin
20%
Patient Care
19%
Patient Readmission
18%
Survival
18%
Cancer Care Facilities
18%
Physicians
18%
Critical Pathways
17%
exemestane
16%
Neoadjuvant Therapy
15%
Programmed Cell Death 1 Receptor
15%
Hormones
15%
Palliative Care
15%
Data Science
15%
Health
14%
Progression-Free Survival
14%
Fulvestrant
14%
Postal Service
14%
Text Messaging
14%
Centers for Medicare and Medicaid Services (U.S.)
14%
Referral and Consultation
14%
Insurance
14%
Tumor-Infiltrating Lymphocytes
14%
Everolimus
13%
Aromatase Inhibitors
13%
Hospitalization
13%
Bortezomib
13%
Social Sciences
cancer
100%
electronics
21%
data capture
15%
predictive model
15%
acute care
14%
co-management
14%
patient care
14%
Quality of care
12%
utilization
11%
e-mail
11%
revenue
9%
mortality
9%
time
9%
hospitalization
8%
communication
8%
monitoring
8%
physician
8%
Clinical Trials
8%
comorbidity
8%
health care
7%
expert
7%
decision making
6%
best practice
6%
costs
6%
hospice
6%
public comment
6%
health
5%
clinical pathways
5%